Works by Satoshi Morita

Results: 436
    1
    2
    3

    Postoperative tegafur–uracil for stage I lung adenocarcinoma: first real-world data with an exploratory subgroup analysis.

    Published in:
    Surgery Today, 2023, v. 53, n. 1, p. 135, doi. 10.1007/s00595-022-02546-z
    By:
    • Miyata, Ryo;
    • Hamaji, Masatsugu;
    • Nakakura, Akiyoshi;
    • Morita, Satoshi;
    • Shimazu, Yumeta;
    • Ishikawa, Masashi;
    • Kayawake, Hidenao;
    • Menju, Toshi;
    • Sakaguchi, Yasuto;
    • Sonobe, Makoto;
    • Takahashi, Mamoru;
    • Aoyama, Akihiro;
    • Sumitomo, Ryota;
    • Huang, Cheng-Long;
    • Kono, Tomoya;
    • Miyahara, Ryo;
    • Matsumoto, Akira;
    • Katakura, Hiromichi;
    • Fukada, Takahisa;
    • Sakai, Hiroaki
    Publication type:
    Article
    4

    Are volume-dependent parameters in positron emission tomography predictive of postoperative recurrence after resection in patients with thymic carcinoma?

    Published in:
    Surgery Today, 2021, v. 51, n. 2, p. 322, doi. 10.1007/s00595-020-02045-z
    By:
    • Hamaji, Masatsugu;
    • Koyasu, Sho;
    • Omasa, Mitsugu;
    • Nakakura, Akiyoshi;
    • Morita, Satoshi;
    • Nakagawa, Tatsuo;
    • Miyahara, So;
    • Miyata, Ryo;
    • Yokoyama, Yuhei;
    • Kawakami, Kenzo;
    • Suga, Michiharu;
    • Takahashi, Mamoru;
    • Terada, Yasuji;
    • Muranishi, Yusuke;
    • Miyahara, Ryo;
    • Sumitomo, Ryota;
    • Huang, Cheng-Long;
    • Aoyama, Akihiro;
    • Takahashi, Yutaka;
    • Date, Hiroshi
    Publication type:
    Article
    5

    Daikenchuto accelerates the recovery from prolonged postoperative ileus after open abdominal surgery: a subgroup analysis of three randomized controlled trials.

    Published in:
    Surgery Today, 2019, v. 49, n. 8, p. 704, doi. 10.1007/s00595-019-01787-9
    By:
    • Kono, Toru;
    • Shimada, Mitsuo;
    • Nishi, Masaaki;
    • Morine, Yuji;
    • Yoshikawa, Kozo;
    • Katsuno, Hidetoshi;
    • Maeda, Koutarou;
    • Koeda, Keisuke;
    • Morita, Satoshi;
    • Watanabe, Masahiko;
    • Kusano, Mitsuo;
    • Sakamoto, Junichi;
    • Saji, Shigetoyo;
    • Sokuoka, Hiroki;
    • Sato, Yasuto;
    • Maehara, Yoshihiko;
    • Kanematsu, Takashi;
    • Kitajima, Masaki
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Prognostic Factors and Efficacy of First‐Line Chemotherapy in Patients with Advanced Thymic Carcinoma: A Retrospective Analysis of 286 Patients from NEJ023 Study.

    Published in:
    Oncologist, 2018, v. 23, n. 10, p. 1210, doi. 10.1634/theoncologist.2017-0586
    By:
    • Ko, Ryo;
    • Shukuya, Takehito;
    • Okuma, Yusuke;
    • Tateishi, Kazunari;
    • Imai, Hisao;
    • Iwasawa, Shunichiro;
    • Miyauchi, Eisaku;
    • Fujiwara, Akiko;
    • Sugiyama, Tomohide;
    • Azuma, Keisuke;
    • Muraki, Keiko;
    • Yamasaki, Masahiro;
    • Tanaka, Hisashi;
    • Takashima, Yuta;
    • Soda, Sayo;
    • Ishimoto, Osamu;
    • Koyama, Nobuyuki;
    • Morita, Satoshi;
    • Kobayashi, Kunihiko;
    • Nukiwa, Toshihiro
    Publication type:
    Article
    15

    Multicenter open-label randomized phase II study of second-line panitumumab and irinotecan with or without fluoropyrimidines in patients with KRAS wild-type metastatic colorectal cancer (PACIFIC study).

    Published in:
    2019
    By:
    • Nagata, Naoki;
    • Maeda, Hiromichi;
    • Ishibashi, Keiichiro;
    • Hirata, Keiji;
    • Makiyama, Akitaka;
    • Iwamoto, Shigeyoshi;
    • Takemoto, Hiroyoshi;
    • Imasato, Mitsunobu;
    • Yoshida, Yoichiro;
    • Munemoto, Yoshinori;
    • Tanaka, Chihiro;
    • Morita, Yoshitaka;
    • Hotta, Yoshihiro;
    • Toyofuku, Atsushi;
    • Nagasaka, Takeshi;
    • Morita, Satoshi;
    • Sakamoto, Junichi;
    • Mishima, Hideyuki
    Publication type:
    journal article
    16
    17
    18
    19
    20
    21

    WT1 peptide vaccine induces reduction in minimal residual disease in an Imatinib-treated CML patient.

    Published in:
    European Journal of Haematology, 2010, v. 85, n. 4, p. 358, doi. 10.1111/j.1600-0609.2010.01497.x
    By:
    • Oji, Yusuke;
    • Oka, Yoshihiro;
    • Nishida, Sumiyuki;
    • Tsuboi, Akihiro;
    • Kawakami, Manabu;
    • Shirakata, Toshiaki;
    • Takahashi, Kazuko;
    • Murao, Ayako;
    • Nakajima, Hiroko;
    • Narita, Miwako;
    • Takahashi, Masuhiro;
    • Morita, Satoshi;
    • Sakamoto, Junichi;
    • Tanaka, Toshio;
    • Kawase, Ichiro;
    • Hosen, Naoki;
    • Sugiyama, Haruo
    Publication type:
    Article
    22
    23

    Factors affecting prognosis in patients treated with bevacizumab plus paclitaxel as first-line chemotherapy for HER2-negative metastatic breast cancer: an international pooled analysis of individual patient data from four prospective observational studies

    Published in:
    Breast Cancer (13406868), 2023, v. 30, n. 1, p. 88, doi. 10.1007/s12282-022-01399-1
    By:
    • Yamamoto, Yutaka;
    • Yamashiro, Hiroyasu;
    • Schneeweiss, Andreas;
    • Müller, Volkmar;
    • Gluz, Oleg;
    • Klare, Peter;
    • Aktas, Bahriye;
    • Magdolna, Dank;
    • Büdi, László;
    • Pikó, Béla;
    • Mangel, László;
    • Toi, Masakazu;
    • Morita, Satoshi;
    • Ohno, Shinji
    Publication type:
    Article
    24

    Prospective observational study of bevacizumab combined with paclitaxel as first- or second-line chemotherapy for locally advanced or metastatic breast cancer: the JBCRG-C05 (B-SHARE) study.

    Published in:
    Breast Cancer (13406868), 2021, v. 28, n. 1, p. 145, doi. 10.1007/s12282-020-01138-4
    By:
    • Yamamoto, Yutaka;
    • Yamashiro, Hiroyasu;
    • Toh, Uhi;
    • Kondo, Naoto;
    • Nakamura, Rikiya;
    • Kashiwaba, Masahiro;
    • Takahashi, Masato;
    • Tsugawa, Koichiro;
    • Ishikawa, Takashi;
    • Nakayama, Takahiro;
    • Ohtani, Shoichiro;
    • Takano, Toshimi;
    • Fujisawa, Tomomi;
    • Toyama, Tatsuya;
    • Kawaguchi, Hidetoshi;
    • Mashino, Kojiro;
    • Tanino, Yuichi;
    • Morita, Satoshi;
    • Toi, Masakazu;
    • Ohno, Shinji
    Publication type:
    Article
    25

    Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients: extended follow-up of JBCRG-cohort study 01.

    Published in:
    Breast Cancer (13406868), 2020, v. 27, n. 4, p. 631, doi. 10.1007/s12282-020-01057-4
    By:
    • Yamashiro, Hiroyasu;
    • Iwata, Hiroji;
    • Masuda, Norikazu;
    • Yamamoto, Naohito;
    • Nishimura, Reiki;
    • Ohtani, Shoichiro;
    • Sato, Nobuaki;
    • Takahashi, Masato;
    • Kamio, Takako;
    • Yamazaki, Kosuke;
    • Saito, Tsuyoshi;
    • Kato, Makoto;
    • Lee, Tecchuu;
    • Kuroi, Katsumasa;
    • Takano, Toshimi;
    • Yasuno, Shinji;
    • Morita, Satoshi;
    • Ohno, Shinji;
    • Toi, Masakazu;
    • the JBCRG-C01 Collaborative Group
    Publication type:
    Article
    26

    Factors associated with prolonged overall survival in patients with postmenopausal estrogen receptor-positive advanced breast cancer using real-world data: a follow-up analysis of the JBCRG-C06 Safari study.

    Published in:
    Breast Cancer (13406868), 2020, v. 27, n. 3, p. 389, doi. 10.1007/s12282-019-01029-3
    By:
    • Kawaguchi, Hidetoshi;
    • Masuda, Norikazu;
    • Nakayama, Takahiro;
    • Aogi, Kenjiro;
    • Anan, Keisei;
    • Ito, Yoshinori;
    • Ohtani, Shoichiro;
    • Sato, Nobuaki;
    • Saji, Shigehira;
    • Takano, Toshimi;
    • Tokunaga, Eriko;
    • Nakamura, Seigo;
    • Hasegawa, Yoshie;
    • Hattori, Masaya;
    • Fujisawa, Tomomi;
    • Morita, Satoshi;
    • Yamaguchi, Miki;
    • Yamashita, Hiroko;
    • Yamashita, Toshinari;
    • Yamamoto, Yutaka
    Publication type:
    Article
    27
    28

    Bi-weekly eribulin therapy for metastatic breast cancer: a multicenter phase II prospective study (JUST-STUDY).

    Published in:
    Breast Cancer (13406868), 2018, v. 25, n. 4, p. 438, doi. 10.1007/s12282-018-0843-y
    By:
    • Ohtani, Shoichiro;
    • Nakayama, Takahiro;
    • Yoshinami, Tetsuhiro;
    • Watanabe, Ken-ichi;
    • Hara, Fumikata;
    • Sagara, Yasuaki;
    • Kawaguchi, Hidetoshi;
    • Higaki, Kenji;
    • Matsunami, Nobuki;
    • Hasegawa, Yoshie;
    • Takahashi, Masato;
    • Mizutani, Makiko;
    • Morimoto, Takashi;
    • Sato, Masako;
    • Itoh, Mitsuya;
    • Morita, Satoshi;
    • Masuda, Norikazu
    Publication type:
    Article
    29
    30
    31
    32

    A phase 1/2 study of gilteritinib in combination with chemotherapy in newly diagnosed patients with AML in Asia.

    Published in:
    International Journal of Hematology, 2025, v. 121, n. 1, p. 56, doi. 10.1007/s12185-024-03840-x
    By:
    • Sawa, Masashi;
    • Miyamoto, Toshihiro;
    • Kim, Hee-Je;
    • Hiramatsu, Yasushi;
    • Cheong, June-Won;
    • Ikezoe, Takayuki;
    • Naoe, Tomoki;
    • Akashi, Koichi;
    • Morita, Satoshi;
    • Kosako, Masanori;
    • Ikegaya, Moyu;
    • Terada, Wataru;
    • Kadokura, Takeshi;
    • Hill, Jason;
    • Miyawaki, Shuichi;
    • Gill, Stanley C.;
    • Heinloth, Alexandra;
    • Hasabou, Nahla
    Publication type:
    Article
    33
    34

    A comparison of tacrolimus and cyclosporine combined with methotrexate for graft-versus-host disease prophylaxis, stratified by stem cell source: a retrospective nationwide survey.

    Published in:
    2016
    By:
    • Sakai, Rika;
    • Taguri, Masataka;
    • Oshima, Kumi;
    • Mori, Takehiko;
    • Ago, Hiroatsu;
    • Adachi, Souichi;
    • Morita, Satoshi;
    • Taniguchi, Shuichi;
    • Fukuda, Takahiro;
    • Ohashi, Kazuteru;
    • Eto, Tetsuya;
    • Miyamura, Koichi;
    • Iwato, Koji;
    • Kobayashi, Naoki;
    • Kanamori, Heiwa;
    • Morishima, Yasuo;
    • Nagamura-Inoue, Tokiko;
    • Sakamaki, Hisashi;
    • Atsuta, Yoshiko;
    • Murata, Makoto
    Publication type:
    journal article
    35

    Wilms tumor gene WT1 peptide-based immunotherapy induced a minimal response in a patient with advanced therapy-resistant multiple myeloma.

    Published in:
    2007
    By:
    • Tsuboi, Akihiro;
    • Oka, Yoshihiro;
    • Nakajima, Hiroko;
    • Fukuda, Yoko;
    • Elisseeva, Olga A;
    • Yoshihara, Satoshi;
    • Hosen, Naoki;
    • Ogata, Atsushi;
    • Kito, Katsuyuki;
    • Fujiki, Fumihiro;
    • Nishida, Sumiyuki;
    • Shirakata, Toshiaki;
    • Ohno, Satoshi;
    • Yasukawa, Masaki;
    • Oji, Yusuke;
    • Kawakami, Manabu;
    • Morita, Satoshi;
    • Sakamoto, Junichi;
    • Udaka, Keiko;
    • Kawase, Ichiro
    Publication type:
    journal article
    36
    37
    38

    Immune‐related adverse events in urothelial cancer patients: Adjustment for immortal time bias.

    Published in:
    Cancer Science, 2022, v. 113, n. 11, p. 3912, doi. 10.1111/cas.15539
    By:
    • Otsuka, Hikari;
    • Kita, Yuki;
    • Ito, Katsuhiro;
    • Sano, Takeshi;
    • Inokuchi, Junichi;
    • Tomida, Ryotaro;
    • Takahashi, Atsushi;
    • Matsumoto, Kazumasa;
    • Kurahashi, Ryoma;
    • Ozaki, Yu;
    • Uegaki, Masayuki;
    • Maruyama, Satoru;
    • Mukai, Shoichiro;
    • Tsutsumi, Masakazu;
    • Kawahara, Takashi;
    • Segawa, Takehiko;
    • Kitamura, Hiroshi;
    • Morita, Satoshi;
    • Kobayashi, Takashi
    Publication type:
    Article
    39

    Pertuzumab retreatment for HER2‐positive advanced breast cancer: A randomized, open‐label phase III study (PRECIOUS).

    Published in:
    Cancer Science, 2022, v. 113, n. 9, p. 3169, doi. 10.1111/cas.15474
    By:
    • Yamamoto, Yutaka;
    • Iwata, Hiroji;
    • Taira, Naruto;
    • Masuda, Norikazu;
    • Takahashi, Masato;
    • Yoshinami, Tetsuhiro;
    • Ueno, Takayuki;
    • Toyama, Tatsuya;
    • Yamanaka, Takashi;
    • Takano, Toshimi;
    • Kashiwaba, Masahiro;
    • Tsugawa, Koichiro;
    • Hasegawa, Yoshie;
    • Tamura, Kenji;
    • Tada, Hiroshi;
    • Hara, Fumikata;
    • Fujisawa, Tomomi;
    • Niikura, Naoki;
    • Saji, Shigehira;
    • Morita, Satoshi
    Publication type:
    Article
    40

    Impact of UGT1A1 genotype on the efficacy and safety of irinotecan-based chemotherapy in metastatic colorectal cancer.

    Published in:
    Cancer Science, 2021, v. 112, n. 11, p. 4669, doi. 10.1111/cas.15092
    By:
    • Satoru Iwasa;
    • Kei Muro;
    • Satoshi Morita;
    • Young Suk Park;
    • Masato Nakamura;
    • Masahito Kotaka;
    • Tomohiro Nishina;
    • Hiroshi Matsuoka;
    • Joong Bae Ahn;
    • Keun-Wook Lee;
    • Yong Sang Hong;
    • Sae Won Han;
    • Sang-Hee Cho;
    • Dong-Sheng Zhang;
    • Wei-Jia Fang;
    • Li Bai;
    • Xiang-Lin Yuan;
    • Ying Yuan;
    • Yasuhide Yamada;
    • Junichi Sakamoto
    Publication type:
    Article
    41

    Silent NK/T cell reactions to dasatinib during sustained deep molecular response before cessation are associated with longer treatment‐free remission.

    Published in:
    Cancer Science, 2020, v. 111, n. 8, p. 2923, doi. 10.1111/cas.14518
    By:
    • Kumagai, Takashi;
    • Nakaseko, Chiaki;
    • Nishiwaki, Kaichi;
    • Yoshida, Chikashi;
    • Ohashi, Kazuteru;
    • Takezako, Naoki;
    • Takano, Hina;
    • Kouzai, Yasuji;
    • Murase, Tadashi;
    • Matsue, Kosei;
    • Morita, Satoshi;
    • Sakamoto, Junichi;
    • Wakita, Hisashi;
    • Sakamaki, Hisashi;
    • Inokuchi, Koiti
    Publication type:
    Article
    42
    43

    Clinical activity of ASP8273 in Asian patients with non‐small‐cell lung cancer with EGFR activating and T790M mutations.

    Published in:
    Cancer Science, 2018, v. 109, n. 9, p. 2852, doi. 10.1111/cas.13724
    By:
    • Murakami, Haruyasu;
    • Nokihara, Hiroshi;
    • Hayashi, Hidetoshi;
    • Seto, Takashi;
    • Park, Keunchil;
    • Azuma, Koichi;
    • Tsai, Chun‐Ming;
    • Yang, James Chih‐Hsin;
    • Nishio, Makoto;
    • Kim, Sang‐We;
    • Kiura, Katsuyuki;
    • Inoue, Akira;
    • Takeda, Koji;
    • Kang, Jin‐Hyoung;
    • Nakagawa, Tomoki;
    • Takeda, Kentaro;
    • Akazawa, Rio;
    • Kaneko, Yuichiro;
    • Shimazaki, Masashi;
    • Morita, Satoshi
    Publication type:
    Article
    44

    ASP8273 tolerability and antitumor activity in tyrosine kinase inhibitor‐naïve Japanese patients with EGFR mutation‐positive non‐small‐cell lung cancer.

    Published in:
    Cancer Science, 2018, v. 109, n. 8, p. 2532, doi. 10.1111/cas.13651
    By:
    • Azuma, Koichi;
    • Nishio, Makoto;
    • Hayashi, Hidetoshi;
    • Kiura, Katsuyuki;
    • Satouchi, Miyako;
    • Sugawara, Shunichi;
    • Hida, Toyoaki;
    • Iwamoto, Yasuo;
    • Inoue, Akira;
    • Takeda, Koji;
    • Ikeda, Satoshi;
    • Nakagawa, Tomoki;
    • Takeda, Kentaro;
    • Asahina, Seitaro;
    • Komatsu, Kanji;
    • Morita, Satoshi;
    • Fukuoka, Masahiro;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    45

    Dasatinib cessation after deep molecular response exceeding 2 years and natural killer cell transition during dasatinib consolidation.

    Published in:
    Cancer Science, 2018, v. 109, n. 1, p. 182, doi. 10.1111/cas.13430
    By:
    • Kumagai, Takashi;
    • Nakaseko, Chiaki;
    • Nishiwaki, Kaichi;
    • Yoshida, Chikashi;
    • Ohashi, Kazuteru;
    • Takezako, Naoki;
    • Takano, Hina;
    • Kouzai, Yasuji;
    • Murase, Tadashi;
    • Matsue, Kosei;
    • Morita, Satoshi;
    • Sakamoto, Junichi;
    • Wakita, Hisashi;
    • Sakamaki, Hisashi;
    • Inokuchi, Koiti;
    • the Kanto CML and Shimousa Hematology Study Groups
    Publication type:
    Article
    46
    47

    Semaphorin 4D, a lymphocyte semaphorin, enhances tumor cell motility through binding its receptor, plexinB1, in pancreatic cancer.

    Published in:
    Cancer Science, 2011, v. 102, n. 11, p. 2029, doi. 10.1111/j.1349-7006.2011.02053.x
    By:
    • Kato, Shingo;
    • Kubota, Kensuke;
    • Shimamura, Takeshi;
    • Shinohara, Yoshiyasu;
    • Kobayashi, Noritoshi;
    • Watanabe, Seitaro;
    • Yoneda, Masato;
    • Inamori, Masahiko;
    • Nakamura, Fumio;
    • Ishiguro, Hitoshi;
    • Nakaigawa, Noboru;
    • Nagashima, Yoji;
    • Taguri, Masataka;
    • Kubota, Yoshinobu;
    • Goshima, Yoshio;
    • Morita, Satoshi;
    • Endo, Itaru;
    • Maeda, Shin;
    • Nakajima, Atsushi;
    • Nakagama, Hitoshi
    Publication type:
    Article
    48
    49
    50

    Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trial.

    Published in:
    Supportive Care in Cancer, 2012, v. 20, n. 12, p. 3355, doi. 10.1007/s00520-012-1492-x
    By:
    • Shimozuma, Kojiro;
    • Ohashi, Yasuo;
    • Takeuchi, Ayano;
    • Aranishi, Toshihiko;
    • Morita, Satoshi;
    • Kuroi, Katsumasa;
    • Ohsumi, Shozo;
    • Makino, Haruhiko;
    • Katsumata, Noriyuki;
    • Kuranami, Masaru;
    • Suemasu, Kimito;
    • Watanabe, Toru;
    • Hausheer, Frederick
    Publication type:
    Article